Amundi - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
Amundi ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$81,643
-12.1%
4,6520.0%0.00%
Q2 2023$92,854
+3.3%
4,652
-14.2%
0.00%
Q1 2023$89,901
-19.0%
5,4190.0%0.00%
Q4 2022$110,927
+65.6%
5,419
+39.5%
0.00%
Q3 2022$67,000
-5.6%
3,885
+1.3%
0.00%
Q4 2021$71,000
-38.3%
3,8360.0%0.00%
Q3 2021$115,000
-32.4%
3,8360.0%0.00%
Q2 2021$170,0003,8360.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders